The exit of insurers from exchanges created by the Affordable Care Act represents a fresh challenge to the viability of the president's signature health care law.
It can be hard to figure out if genetic tests for breast and ovarian cancer and other services important to women are covered, because health plans often don't list them in the summary of benefits.
Insurers have released the latest lists of prescription drugs they won't cover in 2017. Express Scripts is excluding 85 drugs and CVS Caremark, 131. Some drugs for diabetes and asthma are out.
Evidence shows dominant insurers hold down hospital prices. Big insurers seeking to get bigger want to take that idea to the extreme. Hospitals and doctors object.
Most employees at large companies should expect a 5 percent increase in their health insurance premiums in 2017 and few changes to the coverage and features.
Medicaid and other health insurers require doctors to file time-consuming paperwork before allowing them to prescribe drugs that help people quit opioids. That delay fosters relapse, specialists say.
Consumers often blame drug companies for the rapidly rising costs of some commonly used generic drugs. But changes made by insurers influence the price of these drugs, too, it turns out.
After two years of moderate rate hikes, a double-digit increase in the cost of insurance premiums in California is likely to resonate across the U.S. in the debate about the benefits of Obamacare.
Despite government policies designed to encourage health coverage for these children, many families are thwarted by confusing rules and regulations, advocacy groups say.